Stock Analysis

Median Technologies Full Year 2024 Earnings: EPS Misses Expectations

ENXTPA:ALMDT
Source: Shutterstock
Advertisement

Median Technologies (EPA:ALMDT) Full Year 2024 Results

Key Financial Results

  • Revenue: €23.0m (flat on FY 2023).
  • Net loss: €25.2m (loss widened by 9.8% from FY 2023).
  • €1.37 loss per share (further deteriorated from €1.25 loss in FY 2023).
earnings-and-revenue-growth
ENXTPA:ALMDT Earnings and Revenue Growth May 5th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Median Technologies EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 14%.

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.

Performance of the market in France.

The company's shares are down 7.1% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Median Technologies (2 can't be ignored) you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ENXTPA:ALMDT

Median Technologies

Develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.

Slight and slightly overvalued.

Advertisement